Fertility Growth Opportunity to expand sales in fertility products and services driven by revenue growth of approximately 8 percent in fiscal 2025 and Fertility revenue increasing in Q3 2026, indicating strong demand and potential for upsell of complementary fertility technologies and services.

European Direct Sales Strategic shift to a direct sales model for Labor and Delivery in key European markets presents a pathway to introduce broader product lines, training services, and bundled solutions to hospitals and clinics in the region.

Sustainability Pilot Collaborative recycling pilot for IVF plastics with Adora Fertility and Transmutation signals an openness to sustainable packaging and waste-reduction programs, creating opportunities for sales of eco-friendly materials, recycling-enabled service contracts, and compliance-focused offerings.

Clinical Partnerships Active clinic wins and ongoing collaborations point to a strong channel for expanding workflow-integrated solutions, including genomics-enabled diagnostics, imaging, and office-based procedures that can be offered as integrated packages to clinics.

Risk & Quality Regulatory and quality assurance considerations are highlighted by past litigation related to embryo culture products; a sales approach should emphasize robust quality, safety, and provider support packages to differentiate offerings and address clinician concerns.